Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Pet Therapeutics Market Growth (Status and Outlook) 2022-2028

  • LP 4943152
  • 89 Pages
  • April 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Pet Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Pet Therapeutics market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Pet Therapeutics market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Pet Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Pet Therapeutics market, reaching US$ million by the year 2028. As for the Europe Pet Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Pet Therapeutics players cover Elanco, Boehringer Ingelheim GmbH, Ceva Sante Animale, and Dechra Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Pet Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Infectious Diseases

Dermatological Diseases

Orthopedic Diseases

Behavioral Disorders

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Dogs

Cats

Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Elanco

Boehringer Ingelheim GmbH

Ceva Sante Animale

Dechra Pharmaceuticals

Eli Lilly and Company

Merck

Vetoquinol

Zoetis

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Pet Therapeutics Market Size 2017-2028

2.1.2 Pet Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Pet Therapeutics Segment by Type

2.2.1 Infectious Diseases

2.2.2 Dermatological Diseases

2.2.3 Orthopedic Diseases

2.2.4 Behavioral Disorders

2.2.5 Others

2.3 Pet Therapeutics Market Size by Type

2.3.1 Pet Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Pet Therapeutics Market Size Market Share by Type (2017-2022)

2.4 Pet Therapeutics Segment by Application

2.4.1 Dogs

2.4.2 Cats

2.4.3 Other

2.5 Pet Therapeutics Market Size by Application

2.5.1 Pet Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Pet Therapeutics Market Size Market Share by Application (2017-2022)

3 Pet Therapeutics Market Size by Player

3.1 Pet Therapeutics Market Size Market Share by Players

3.1.1 Global Pet Therapeutics Revenue by Players (2020-2022)

3.1.2 Global Pet Therapeutics Revenue Market Share by Players (2020-2022)

3.2 Global Pet Therapeutics Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Pet Therapeutics by Regions

4.1 Pet Therapeutics Market Size by Regions (2017-2022)

4.2 Americas Pet Therapeutics Market Size Growth (2017-2022)

4.3 APAC Pet Therapeutics Market Size Growth (2017-2022)

4.4 Europe Pet Therapeutics Market Size Growth (2017-2022)

4.5 Middle East & Africa Pet Therapeutics Market Size Growth (2017-2022)

5 Americas

5.1 Americas Pet Therapeutics Market Size by Country (2017-2022)

5.2 Americas Pet Therapeutics Market Size by Type (2017-2022)

5.3 Americas Pet Therapeutics Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Pet Therapeutics Market Size by Region (2017-2022)

6.2 APAC Pet Therapeutics Market Size by Type (2017-2022)

6.3 APAC Pet Therapeutics Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Pet Therapeutics by Country (2017-2022)

7.2 Europe Pet Therapeutics Market Size by Type (2017-2022)

7.3 Europe Pet Therapeutics Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Pet Therapeutics by Region (2017-2022)

8.2 Middle East & Africa Pet Therapeutics Market Size by Type (2017-2022)

8.3 Middle East & Africa Pet Therapeutics Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Pet Therapeutics Market Forecast

10.1 Global Pet Therapeutics Forecast by Regions (2023-2028)

10.1.1 Global Pet Therapeutics Forecast by Regions (2023-2028)

10.1.2 Americas Pet Therapeutics Forecast

10.1.3 APAC Pet Therapeutics Forecast

10.1.4 Europe Pet Therapeutics Forecast

10.1.5 Middle East & Africa Pet Therapeutics Forecast

10.2 Americas Pet Therapeutics Forecast by Country (2023-2028)

10.2.1 United States Pet Therapeutics Market Forecast

10.2.2 Canada Pet Therapeutics Market Forecast

10.2.3 Mexico Pet Therapeutics Market Forecast

10.2.4 Brazil Pet Therapeutics Market Forecast

10.3 APAC Pet Therapeutics Forecast by Region (2023-2028)

10.3.1 China Pet Therapeutics Market Forecast

10.3.2 Japan Pet Therapeutics Market Forecast

10.3.3 Korea Pet Therapeutics Market Forecast

10.3.4 Southeast Asia Pet Therapeutics Market Forecast

10.3.5 India Pet Therapeutics Market Forecast

10.3.6 Australia Pet Therapeutics Market Forecast

10.4 Europe Pet Therapeutics Forecast by Country (2023-2028)

10.4.1 Germany Pet Therapeutics Market Forecast

10.4.2 France Pet Therapeutics Market Forecast

10.4.3 UK Pet Therapeutics Market Forecast

10.4.4 Italy Pet Therapeutics Market Forecast

10.4.5 Russia Pet Therapeutics Market Forecast

10.5 Middle East & Africa Pet Therapeutics Forecast by Region (2023-2028)

10.5.1 Egypt Pet Therapeutics Market Forecast

10.5.2 South Africa Pet Therapeutics Market Forecast

10.5.3 Israel Pet Therapeutics Market Forecast

10.5.4 Turkey Pet Therapeutics Market Forecast

10.5.5 GCC Countries Pet Therapeutics Market Forecast

10.6 Global Pet Therapeutics Forecast by Type (2023-2028)

10.7 Global Pet Therapeutics Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Elanco

11.1.1 Elanco Company Information

11.1.2 Elanco Pet Therapeutics Product Offered

11.1.3 Elanco Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Elanco Main Business Overview

11.1.5 Elanco Latest Developments

11.2 Boehringer Ingelheim GmbH

11.2.1 Boehringer Ingelheim GmbH Company Information

11.2.2 Boehringer Ingelheim GmbH Pet Therapeutics Product Offered

11.2.3 Boehringer Ingelheim GmbH Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Boehringer Ingelheim GmbH Main Business Overview

11.2.5 Boehringer Ingelheim GmbH Latest Developments

11.3 Ceva Sante Animale

11.3.1 Ceva Sante Animale Company Information

11.3.2 Ceva Sante Animale Pet Therapeutics Product Offered

11.3.3 Ceva Sante Animale Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Ceva Sante Animale Main Business Overview

11.3.5 Ceva Sante Animale Latest Developments

11.4 Dechra Pharmaceuticals

11.4.1 Dechra Pharmaceuticals Company Information

11.4.2 Dechra Pharmaceuticals Pet Therapeutics Product Offered

11.4.3 Dechra Pharmaceuticals Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Dechra Pharmaceuticals Main Business Overview

11.4.5 Dechra Pharmaceuticals Latest Developments

11.5 Eli Lilly and Company

11.5.1 Eli Lilly and Company Company Information

11.5.2 Eli Lilly and Company Pet Therapeutics Product Offered

11.5.3 Eli Lilly and Company Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Eli Lilly and Company Main Business Overview

11.5.5 Eli Lilly and Company Latest Developments

11.6 Merck

11.6.1 Merck Company Information

11.6.2 Merck Pet Therapeutics Product Offered

11.6.3 Merck Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Merck Main Business Overview

11.6.5 Merck Latest Developments

11.7 Vetoquinol

11.7.1 Vetoquinol Company Information

11.7.2 Vetoquinol Pet Therapeutics Product Offered

11.7.3 Vetoquinol Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Vetoquinol Main Business Overview

11.7.5 Vetoquinol Latest Developments

11.8 Zoetis

11.8.1 Zoetis Company Information

11.8.2 Zoetis Pet Therapeutics Product Offered

11.8.3 Zoetis Pet Therapeutics Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Zoetis Main Business Overview

11.8.5 Zoetis Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Pet Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Infectious Diseases

Table 3. Major Players of Dermatological Diseases

Table 4. Major Players of Orthopedic Diseases

Table 5. Major Players of Behavioral Disorders

Table 6. Major Players of Others

Table 7. Pet Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Pet Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Pet Therapeutics Market Size Market Share by Type (2017-2022)

Table 10. Pet Therapeutics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Pet Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Pet Therapeutics Market Size Market Share by Application (2017-2022)

Table 13. Global Pet Therapeutics Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Pet Therapeutics Revenue Market Share by Player (2020-2022)

Table 15. Pet Therapeutics Key Players Head office and Products Offered

Table 16. Pet Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Pet Therapeutics Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Pet Therapeutics Market Size Market Share by Regions (2017-2022)

Table 21. Americas Pet Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Pet Therapeutics Market Size Market Share by Country (2017-2022)

Table 23. Americas Pet Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Pet Therapeutics Market Size Market Share by Type (2017-2022)

Table 25. Americas Pet Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Pet Therapeutics Market Size Market Share by Application (2017-2022)

Table 27. APAC Pet Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Pet Therapeutics Market Size Market Share by Region (2017-2022)

Table 29. APAC Pet Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Pet Therapeutics Market Size Market Share by Type (2017-2022)

Table 31. APAC Pet Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Pet Therapeutics Market Size Market Share by Application (2017-2022)

Table 33. Europe Pet Therapeutics Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Pet Therapeutics Market Size Market Share by Country (2017-2022)

Table 35. Europe Pet Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Pet Therapeutics Market Size Market Share by Type (2017-2022)

Table 37. Europe Pet Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Pet Therapeutics Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Pet Therapeutics Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Pet Therapeutics Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Pet Therapeutics Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Pet Therapeutics Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Pet Therapeutics Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Pet Therapeutics Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Pet Therapeutics

Table 46. Key Market Challenges & Risks of Pet Therapeutics

Table 47. Key Industry Trends of Pet Therapeutics

Table 48. Global Pet Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Pet Therapeutics Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Pet Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Pet Therapeutics Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Pet Therapeutics Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Pet Therapeutics Market Size Market Share Forecast by Application (2023-2028)

Table 54. Elanco Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 55. Elanco Pet Therapeutics Product Offered

Table 56. Elanco Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Elanco Main Business

Table 58. Elanco Latest Developments

Table 59. Boehringer Ingelheim GmbH Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 60. Boehringer Ingelheim GmbH Pet Therapeutics Product Offered

Table 61. Boehringer Ingelheim GmbH Main Business

Table 62. Boehringer Ingelheim GmbH Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Boehringer Ingelheim GmbH Latest Developments

Table 64. Ceva Sante Animale Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 65. Ceva Sante Animale Pet Therapeutics Product Offered

Table 66. Ceva Sante Animale Main Business

Table 67. Ceva Sante Animale Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Ceva Sante Animale Latest Developments

Table 69. Dechra Pharmaceuticals Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 70. Dechra Pharmaceuticals Pet Therapeutics Product Offered

Table 71. Dechra Pharmaceuticals Main Business

Table 72. Dechra Pharmaceuticals Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Dechra Pharmaceuticals Latest Developments

Table 74. Eli Lilly and Company Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 75. Eli Lilly and Company Pet Therapeutics Product Offered

Table 76. Eli Lilly and Company Main Business

Table 77. Eli Lilly and Company Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. Eli Lilly and Company Latest Developments

Table 79. Merck Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 80. Merck Pet Therapeutics Product Offered

Table 81. Merck Main Business

Table 82. Merck Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. Merck Latest Developments

Table 84. Vetoquinol Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 85. Vetoquinol Pet Therapeutics Product Offered

Table 86. Vetoquinol Main Business

Table 87. Vetoquinol Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. Vetoquinol Latest Developments

Table 89. Zoetis Details, Company Type, Pet Therapeutics Area Served and Its Competitors

Table 90. Zoetis Pet Therapeutics Product Offered

Table 91. Zoetis Main Business

Table 92. Zoetis Pet Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Zoetis Latest Developments

List of Figures

Figure 1. Pet Therapeutics Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Pet Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Pet Therapeutics Market Size Market Share by Type in 2021

Figure 7. Pet Therapeutics in Dogs

Figure 8. Global Pet Therapeutics Market: Dogs (2017-2022) & ($ Millions)

Figure 9. Pet Therapeutics in Cats

Figure 10. Global Pet Therapeutics Market: Cats (2017-2022) & ($ Millions)

Figure 11. Pet Therapeutics in Other

Figure 12. Global Pet Therapeutics Market: Other (2017-2022) & ($ Millions)

Figure 13. Global Pet Therapeutics Market Size Market Share by Application in 2021

Figure 14. Global Pet Therapeutics Revenue Market Share by Player in 2021

Figure 15. Global Pet Therapeutics Market Size Market Share by Regions (2017-2022)

Figure 16. Americas Pet Therapeutics Market Size 2017-2022 ($ Millions)

Figure 17. APAC Pet Therapeutics Market Size 2017-2022 ($ Millions)

Figure 18. Europe Pet Therapeutics Market Size 2017-2022 ($ Millions)

Figure 19. Middle East & Africa Pet Therapeutics Market Size 2017-2022 ($ Millions)

Figure 20. Americas Pet Therapeutics Value Market Share by Country in 2021

Figure 21. Americas Pet Therapeutics Consumption Market Share by Type in 2021

Figure 22. Americas Pet Therapeutics Market Size Market Share by Application in 2021

Figure 23. United States Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 24. Canada Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 25. Mexico Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 26. Brazil Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 27. APAC Pet Therapeutics Market Size Market Share by Region in 2021

Figure 28. APAC Pet Therapeutics Market Size Market Share by Application in 2021

Figure 29. China Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 30. Japan Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 31. Korea Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 32. Southeast Asia Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 33. India Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 34. Australia Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 35. Europe Pet Therapeutics Market Size Market Share by Country in 2021

Figure 36. Europe Pet Therapeutics Market Size Market Share by Type in 2021

Figure 37. Europe Pet Therapeutics Market Size Market Share by Application in 2021

Figure 38. Germany Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 39. France Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 40. UK Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 41. Italy Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 42. Russia Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 43. Middle East & Africa Pet Therapeutics Market Size Market Share by Region in 2021

Figure 44. Middle East & Africa Pet Therapeutics Market Size Market Share by Type in 2021

Figure 45. Middle East & Africa Pet Therapeutics Market Size Market Share by Application in 2021

Figure 46. Egypt Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 47. South Africa Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 48. Israel Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 49. Turkey Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 50. GCC Country Pet Therapeutics Market Size Growth 2017-2022 ($ Millions)

Figure 51. Americas Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 52. APAC Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 53. Europe Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 54. Middle East & Africa Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 55. United States Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 56. Canada Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 57. Mexico Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 58. Brazil Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 59. China Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 60. Japan Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 61. Korea Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 62. Southeast Asia Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 63. India Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 64. Australia Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 65. Germany Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 66. France Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 67. UK Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 68. Italy Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 69. Russia Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 70. Spain Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 71. Egypt Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 72. South Africa Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 73. Israel Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 74. Turkey Pet Therapeutics Market Size 2023-2028 ($ Millions)

Figure 75. GCC Countries Pet Therapeutics Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390